It’s been an exceptional time for Medovate, its Managing Director, Stuart Thomson and his team.
Not only has Medovate received numerous plaudits about its SAFIRA® technology, but this medical device company has also recently secured additional CE Mark Regulatory Approvals for its game-changing infusion driver, foot pedal, luer syringe, NRFit™ syringe and palm operator.
In this interview, Stuart talks about how the new technologies are intended to further improve patient safety and offer greater control to anaesthetists, the revolutionary surgery on ‘Boss’ the lion, Mercia‘s involvement in its growth, and how key the NHS’ involvement is in creating the products that are bringing the Cambridge-based company success on many different levels.